Skip to main content

Table 5 Logistic regression model predicting SCRA use in an Australian cannabis treatment population (N = 154)

From: The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

Characteristics SCRA use
OR 95%CI p-value
Living arrangements—living with others 0.3 0.1–0.8 0.011
Relationship status—in a relationship 0.4 0.2–0.9 0.020
Cannabis dependence—ICD-10 score 0.8 0.6–0.9 0.012
Cannabis consumer/day—grammes 0.9 0.8–1.0 0.083
Lifetime substance use (excluding cannabis and SCRAs) 1.4 1.1–1.6 0.001
DASS—stress score 1.1 1.0–1.3 0.180
DASS—overall score 1.0 0.9–1.0 0.761